TR200102917T2 - Transformasyonlu byme fakt”r-á1 miktarìnìn tespit edilmesi ve bunun kanser tespiti i‡in kullanìldìĞì metod. - Google Patents

Transformasyonlu byme fakt”r-á1 miktarìnìn tespit edilmesi ve bunun kanser tespiti i‡in kullanìldìĞì metod.

Info

Publication number
TR200102917T2
TR200102917T2 TR2001/02917T TR200102917T TR200102917T2 TR 200102917 T2 TR200102917 T2 TR 200102917T2 TR 2001/02917 T TR2001/02917 T TR 2001/02917T TR 200102917 T TR200102917 T TR 200102917T TR 200102917 T2 TR200102917 T2 TR 200102917T2
Authority
TR
Turkey
Prior art keywords
amount
cancer
transformation
factor
detect
Prior art date
Application number
TR2001/02917T
Other languages
English (en)
Turkish (tr)
Inventor
Jin Seung-Won
Shin Hoon
Lim Chang-Gi
Original Assignee
Hanmi Pharm. Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm. Co., Ltd. filed Critical Hanmi Pharm. Co., Ltd.
Publication of TR200102917T2 publication Critical patent/TR200102917T2/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
TR2001/02917T 1999-04-09 2000-04-10 Transformasyonlu byme fakt”r-á1 miktarìnìn tespit edilmesi ve bunun kanser tespiti i‡in kullanìldìĞì metod. TR200102917T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19990012568 1999-04-09
KR19990043935 1999-10-12

Publications (1)

Publication Number Publication Date
TR200102917T2 true TR200102917T2 (tr) 2002-03-21

Family

ID=26634921

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02917T TR200102917T2 (tr) 1999-04-09 2000-04-10 Transformasyonlu byme fakt”r-á1 miktarìnìn tespit edilmesi ve bunun kanser tespiti i‡in kullanìldìĞì metod.

Country Status (11)

Country Link
EP (1) EP1166112A4 (fr)
JP (1) JP2002541479A (fr)
CN (1) CN1355882A (fr)
AU (1) AU768029B2 (fr)
BR (1) BR0009607A (fr)
CA (1) CA2369892A1 (fr)
ID (1) ID30316A (fr)
MX (1) MXPA01009942A (fr)
NZ (1) NZ514596A (fr)
TR (1) TR200102917T2 (fr)
WO (1) WO2000062062A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1339847A2 (fr) * 2000-11-28 2003-09-03 Amgen, Inc. Molecules associees au facteur de croissance transformant-beta et leurs applications
JP4834835B2 (ja) * 2006-07-27 2011-12-14 国立大学法人浜松医科大学 自閉症の診断薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59195162A (ja) * 1983-04-21 1984-11-06 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の検定用試薬
JPS59216058A (ja) * 1983-05-23 1984-12-06 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の定量法
JPS59226864A (ja) * 1983-06-07 1984-12-20 Toyo Jozo Co Ltd トランスホ−ミンググロスファクタ−の酵素免疫測定法
JPS6018764A (ja) * 1983-07-12 1985-01-30 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の免疫測定法
JPH02126157A (ja) * 1988-11-04 1990-05-15 Tosoh Corp ヒトトランスフォーミンググロースファクターβの免疫学的測定方法
WO1993010215A1 (fr) * 1991-11-15 1993-05-27 Memorial Sloan-Kettering Cancer Center Proteaglicane betaglycane purifiee, compositions et procedes
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods

Also Published As

Publication number Publication date
BR0009607A (pt) 2002-01-08
EP1166112A1 (fr) 2002-01-02
WO2000062062A1 (fr) 2000-10-19
NZ514596A (en) 2003-03-28
AU768029B2 (en) 2003-11-27
MXPA01009942A (es) 2003-07-14
ID30316A (id) 2001-11-22
JP2002541479A (ja) 2002-12-03
CN1355882A (zh) 2002-06-26
EP1166112A4 (fr) 2004-11-10
AU4147100A (en) 2000-11-14
CA2369892A1 (fr) 2000-10-19

Similar Documents

Publication Publication Date Title
Jones MT and reflection: an essential combination
CN202074943U (zh) 一种脉冲电涡流测厚仪
ID23247A (id) Pengukuran tekanan formasi dengan sensor jarak jauh di dalam lubang-bor berselubung
ATE290101T1 (de) Lyophilisierte ligand-rezeptor komplexe zum nachweis und als sensoren
DE19880875D2 (de) Koordinatenmessgerät mit Tastelement und dieses vermessenden optischen Sensor
DE3789848D1 (de) Magnetischer Streuflussfühler zur zerstörungsfreien Prüfung.
FR2786266B1 (fr) Capteur de position a sonde de hall
ATE112086T1 (de) Verfahren zur selbsttätigen eichung oder nacheichung von messungen einer physikalischen grösse.
CY1107872T1 (el) Βασισμενη σε πολωση φθορισμου ομοioγενης δοκιμασια για τον προσδιορισμο δεοξυνιβαλενολης στα δημητριακα
CA2132271A1 (fr) Methode de cueillette de donnees destinee a servir avec des capteurs chimiques
ES2099746T3 (es) Metodo de deteccion y/o dosificacion de hormonas.
TR200102917T2 (tr) Transformasyonlu byme fakt”r-á1 miktarìnìn tespit edilmesi ve bunun kanser tespiti i‡in kullanìldìĞì metod.
CN200975992Y (zh) 基于巨磁电阻传感器的涡流检测装置
DE69907927D1 (de) Chemilumineszenz-immunoassay zum nachweis eines mit der chagas-erkränkung verbundenen analyts in einer probe
DE60118797D1 (de) Verfahren zur detektion und messung der biomasse
TR199903140T2 (xx) Projeksiyon mamografisi i�in ayg�t ve bu ayg�t�n kullan�m� i�in y�ntem.
Russell et al. The British beach and nearshore dynamics (B-BAND) programme
EP1407272A4 (fr) Dosage homogene base sur la polarisation de fluorescence utilise pour detecter les aflatoxines
AU7027600A (en) Sensor probe
WO2003007018A3 (fr) Procede et dispositif pour determiner la dose individuelle dans des champs mixtes de neutrons et de photons
EP0380019A3 (fr) Immuno-essai à polarisation de fluorescence pour la méthadone
AU9326201A (en) Fluorescence polarization-based homogeneous assay for fumonisin determination ingrains
ATE71461T1 (de) Schwangerschaftsnachweis mit ''early pregnancy factor''.
CN2073105U (zh) 砖瓦弯曲度检查尺
EP0219279A3 (fr) Réactif pour la détection et la mesure des produits de condensation d'acétaldéhyde et d'une protéine dans un fluide ainsi que sa préparation et méthode d'utilisation